Diaclone, part of Medix Biochemica, is widely recognized for its expertise in the fields of inflammation, oncology and immunology. The company offers best-in-class monoclonal antibodies, ELISA and ELISpot kits, recombinant proteins and custom services ranging from immunoassay kit development to new antibody discovery using hybridoma and phage display technologies, for a broad range of IVD, life science and pharma customers.
